In a previous study including 614 patients, it was shown that preoperative serum VEGF concentration, independent of Dukes stage, was a strong predictor of overall survival of patients with colorectal cancer (CRC) (Werther et al, 2000). This evidence concerns the gene VEGFA and colorectal carcinoma.